Neuromodulation Treatment of Vestibular Migraines

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 28, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Headache
Interventions
DEVICE

Device

"The following parameters will be set for active treatments using the CVS Device:~* A standardized CVS time-varying waveform lasting approximately 19 minutes will be used. Treatments will be administered up to twice daily. The two daily treatments should ideally be separated by at least one hour.~* The waveform schedule will consist of a warm sawtooth delivered to one ear and a cold sawtooth delivered to the other ear. The warm sawtooth will go from body temperature to 42 °C, and the cold sawtooth will go from body temperature to 17 °C. The two waveforms will be delivered simultaneously, but will have different oscillation frequencies."

Trial Locations (1)

33136

University of Miami Miller School of Medicine, Miami

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Scion NeuroStim

INDUSTRY

lead

University of Miami

OTHER

NCT02866084 - Neuromodulation Treatment of Vestibular Migraines | Biotech Hunter | Biotech Hunter